newsfilter
← Latest News
ACCESS Newswire·

Hancock Jaffe Laboratories Announces Pricing of Upsized $36 Million Offering

Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced the pricing of its upsized underwritten public offering of units for gross proceeds of approximately $36 million, prior to deducting underwriting discounts and commissions and offering expenses payable by the company.